US Reclassifies Marijuana From Schedule I to Schedule III Drug
The Trump administration's Justice Department formally moved to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act, following an executive order signed by President Trump more than four months ago. The change moves marijuana out of the same category as heroin and LSD into a category that includes ketamine and anabolic steroids. The reclassification is expected to have significant implications for the legal cannabis industry.
Progressive outlets such as The Guardian frame the reclassification as a long-overdue correction, noting that marijuana's Schedule I status had placed it alongside far more dangerous substances like heroin and synthetic opioids despite widespread medical and recreational legalization at the state level.
The factual record shows that the Justice Department has completed a rescheduling action directed by a Trump executive order, moving marijuana to Schedule III, a classification that carries fewer federal restrictions but does not legalize the substance federally.
Conservative-leaning outlets like Bloomberg acknowledge the reclassification as a significant policy shift driven by the Trump administration, framing it as a pragmatic regulatory update that could expand legal cannabis commerce and reduce federal-state legal conflict.
The factual record shows that the Justice Department has completed a rescheduling action directed by a Trump executive order, moving marijuana to Schedule III, a classification that carries fewer federal restrictions but does not legalize the substance federally.
The US Justice Department officially reclassified marijuana from Schedule I to Schedule III under the Controlled Substances Act following a presidential executive order.